The in vivo experimental data showed that GCH1 overexpression reversed GNA inhibitory effects against tumor growth, suggesting that GNA suppressed malignant progression regarding NSCLC through targeting GCH1 and inducing ferroptosis. This evidence concerns the gene GCH1 and neoplasm.